Tikun Olam, a leading Israeli cannabis brand and pioneer in cannabis research, continues its US expansion by partnering with Washington DC cultivator Alternative Solutions. The just-inked licensing deal allows Alternative Solutions to grow, manufacture and distribute Tikun–branded products to all five District of Columbia dispensaries.
Tikun Olam’s award-winning premium cannabis products are backed by years of peer-reviewed scientific research and unprecedented clinical data collection, which has shown to deliver symptomatic relief to those suffering from specific conditions such as cancer, PTSD, epilepsy, Crohn’s Disease/Colitis, chronic pain and neuropathy, to name a few.
At the 2017 Canadian Cannabis Awards held November 30 in Toronto, Tikun strains took first place in three categories:
- Top High THC Flower (Eran Almog)
- Top High CBD Flower (Avidekel)
- Top High CDB Oil (Avidekel)
In addition, it placed second in Top Hybrid Flower (Midnight). Tikun’s full line of proprietary strain products–from flower, vape, topicals and tinctures – will be available in Washington DC beginning in 2018.
-
Related Story: Israel Is About To Decriminalize Recreational Marijuana
“Alternative Solutions is thrilled to be Tikun Olam’s exclusive partner in DC,” says Matt Lawson-Baker, COO of Alternative Solutions. “We look forward to making Tikun’s products available at all DC dispensaries, giving access to these clinically proven strains to the more than 5,600 registered MMJ patients in Washington DC.”
The new five-year deal with Alternative Solutions is the latest in a series of licensing agreements struck since Tikun’s U.S. launch in 2015 in Delaware. The recent announcement with the MariMed cannabis network will introduce Tikun’s exclusive strains and products in medical marijuana dispensaries in Rhode Island, Maryland, Massachusetts and Illinois in 2018. Tikun products also launched in Nevada in March 2017 and in Washington State in November.
For more cannabis business news, visit MJ Headline News.
